Clover Corporation Limited (AU:CLV)
ASX:CLV
CLV Stock Chart & Stats
AU$0.80
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.80
AU$0.00(0.00%)
Day’s Range― - ―
52-Week RangeAU$0.38 - AU$1.00
Previous CloseN/A
Volume30.13K
Average Volume (3M)223.73K
Market Cap
AU$167.00M
Enterprise ValueAU$165.51M
Total Cash (Recent Filing)AU$10.27M
Total Debt (Recent Filing)AU$1.26M
Price to Earnings (P/E)7.7
Beta0.02
Next Earnings
Sep 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.19%
Share Statistics
EPS (TTM)0.03
Shares Outstanding166,999,340
10 Day Avg. Volume49,116
30 Day Avg. Volume223,729
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)1.28
Price to Sales (P/S)1.08
P/FCF Ratio13.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.05
Revenue Forecast (FY)AU$89.40M
Bulls Say, Bears Say
Bulls Say
Revenue Growth & MarginsSustained revenue growth with expanding gross and net margins indicates robust demand and improving operational efficiency. That combination supports durable cash generation and reinvestment capacity, enabling the business to fund product development and exports over the next 2–6 months.
Low Leverage, Strong Capital StructureExtremely low leverage and a high equity ratio provide financial flexibility and resilience. This conservative capital structure reduces bankruptcy and refinancing risk, supporting strategic initiatives, R&D or acquisitions without pressuring cash flows in the medium term.
Proprietary IP And Diversified MarketsProprietary liquid-packaging IP creates barriers to entry and supports differentiated product offerings across consumer, industrial and healthcare end markets. Diversified end-market exposure and export channels reduce reliance on any single demand source and support steadier revenues.
Bears Say
Declining Free Cash Flow GrowthA sharp drop in free cash flow growth materially weakens internal funding for capex, dividends or acquisitions. Even with reasonable FCF-to-net-income ratios, a 62% decline suggests working capital strain or investment timing that could constrain flexibility and require external funding.
Moderate Return On EquityROE below double digits signals modest capital efficiency given the strong equity base. With an equity-heavy balance sheet, the company may be underutilising capital, limiting long-term shareholder return potential unless margins or asset turnover improve.
Small Scale And Outsourcing RelianceA small in-house workforce implies limited scale and potential dependence on outsourced manufacturing. That reliance can reduce control over costs, quality and capacity expansion, raising operational and supply-chain risk as the company pursues export growth and larger contracts.
Clover Corporation Limited News
CLV FAQ
What was Clover Corporation Limited’s price range in the past 12 months?
Clover Corporation Limited lowest share price was AU$0.38 and its highest was AU$1.00 in the past 12 months.
What is Clover Corporation Limited’s market cap?
Clover Corporation Limited’s market cap is AU$167.00M.
When is Clover Corporation Limited’s upcoming earnings report date?
Clover Corporation Limited’s upcoming earnings report date is Sep 29, 2026 which is in 180 days.
How were Clover Corporation Limited’s earnings last quarter?
Clover Corporation Limited released its earnings results on Mar 23, 2026. The company reported AU$0.025 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.025.
Is Clover Corporation Limited overvalued?
According to Wall Street analysts Clover Corporation Limited’s price is currently Overvalued.
Does Clover Corporation Limited pay dividends?
Clover Corporation Limited pays a Semiannually dividend of AU$0.01 which represents an annual dividend yield of 2.19%. See more information on Clover Corporation Limited dividends here
What is Clover Corporation Limited’s EPS estimate?
Clover Corporation Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Clover Corporation Limited have?
Clover Corporation Limited has 166,999,340 shares outstanding.
What happened to Clover Corporation Limited’s price movement after its last earnings report?
Clover Corporation Limited reported an EPS of AU$0.025 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 18.792%.
Which hedge fund is a major shareholder of Clover Corporation Limited?
Currently, no hedge funds are holding shares in AU:CLV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Clover Corporation Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CLV Sentiment 100%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$70.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.33%
12-Months-Change
Fundamentals
Return on Equity
12.22%
Trailing 12-Months
Asset Growth
6.81%
Trailing 12-Months
Company Description
Clover Corporation Limited
Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nutrition ingredients. In addition, the company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. Further, it provides products in the areas of active living-immune system and sports, healthy livingbrain and heart, and starting out-infant and child. The company was incorporated in 1988 and is headquartered in Altona North, Australia.
Technical Analysis
Australian Dairy Nutritionals Group
―
Bubs Australia Ltd.
―
Nuchev Pty Ltd
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---